Auransa Company

Auransa is an AI-driven platform for discovering drugs of novel pharmacology from vast amounts of genomics data collected from human disease tissues. The company's platform is used to study molecular disease subtypes and predict compounds and targets for responder patient population. Current internal drug pipeline includes cancer and other diseases. The company has partnership with companies and institutions in biopharma industry.
Technology: Artificial Intelligence, Biotechnology, Health Care, Pharmaceutical, Therapeutics
Industry: Early Drug Development, Preclinical Development
Headquarters: Palo Alto, California, United States
Founded Date: 2014-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 6
Total Funding: 18500000
Last Funding Date: 2020-08-24
Last Funding Type: Series A

Visit Website
info@auransa.com
https://twitter.com/auransainc
Register and Claim Ownership